# Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo

> **NCT01257906** · NA · COMPLETED · sponsor: **Actavis Mid-Atlantic LLC** · enrollment: 1225 (actual)

## Conditions studied

- MILD TO SEVERE ACNE VULGARIS

## Interventions

- **DRUG:** CLIND PHOSPHATE (1.2%) AND TRETINOIN (0.025%) TOPICAL GEL
- **DRUG:** ZIANA®
- **DRUG:** Vehicle Control

## Key facts

- **NCT ID:** NCT01257906
- **Lead sponsor:** Actavis Mid-Atlantic LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 1225 (ACTUAL)
- **Last updated:** 2010-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01257906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01257906, "Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01257906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*